RU2012143977A - Способы и промежуточные соединения для получения макроциклических ингибиторов протеазы hcv - Google Patents
Способы и промежуточные соединения для получения макроциклических ингибиторов протеазы hcv Download PDFInfo
- Publication number
- RU2012143977A RU2012143977A RU2012143977/04A RU2012143977A RU2012143977A RU 2012143977 A RU2012143977 A RU 2012143977A RU 2012143977/04 A RU2012143977/04 A RU 2012143977/04A RU 2012143977 A RU2012143977 A RU 2012143977A RU 2012143977 A RU2012143977 A RU 2012143977A
- Authority
- RU
- Russia
- Prior art keywords
- compound
- oxo
- formula
- salt
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
- C07C201/06—Preparation of nitro compounds
- C07C201/12—Preparation of nitro compounds by reactions not involving the formation of nitro groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
- C07C215/20—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated the carbon skeleton being saturated and containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
- C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
- C07C215/30—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/82—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/57—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/02—Preparation of carboxylic acids or their salts, halides or anhydrides from salts of carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/41—Preparation of salts of carboxylic acids
- C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/42—Separation; Purification; Stabilisation; Use of additives
- C07C51/43—Separation; Purification; Stabilisation; Use of additives by change of the physical state, e.g. crystallisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C61/06—Saturated compounds having a carboxyl group bound to a five-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/03—Preparation of carboxylic acid esters by reacting an ester group with a hydroxy group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/31—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of functional groups containing oxygen only in singly bound form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C69/757—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/28—Only halogen atoms, e.g. cyanuric chloride
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/30—Only oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/18—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/42—Separation; Purification; Stabilisation; Use of additives
- C07C51/487—Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Crystallography & Structural Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Furan Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
1. Способ получения (1R,2R)-4-оксо-1,2-циклопентандикарбоновой кислоты II путем разрешения рацемической 4-оксо-1,2-циклопентандикарбоновой кислоты (V), причем указанный способ включает:а) взаимодействие 4-оксо-1,2-циклопентандикарбновой кислоты (V) с бруцином или (1R,2S)-(-)-эфедрином с получением в результате бис-бруциновой или бис-(1R,2S)-(-)-эфедриновой соли соединения (V), иb) селективное осаждение бис-бруциновой или бис-(1R,2S)-(-)-эфедриновой соли (1R,2R)-4-оксо-1,2-циклопентандикарбоновой кислоты II, при этом бис-бруциновая или бис-(1R,2S)-(-)-эфедриновая соль (1S,2S)-4-оксо-1,2-циклопентандикарбоновой кислоты остается в растворе;с) высвобождение кислоты II путем удаления бруцина или (1R,2S)-(-)-эфедрина из осажденной соли, полученной на стадии (b);что в общих чертах представлено на следующей реакционной схеме:2. Способ получения бициклического лактона VII, включающий восстановление 4-кетоциклопентандикарбоновой кислоты II или ее соли, полученной способом по п.1, до 4-гидрокси-1,2-циклопентандикарбоновой кислоты (VI), которую циклизуют до лактона (VII), что показано на следующей реакционной схеме:3. Способ получения циклопентанового производного XVIII, где бициклический лактон VII вводят в реакцию с N-метилгексенамином (NMHA) XVI в реакции амидообразования с получением амида бициклического лактона (XVII), в котором лактоновую группу раскрывают с получением целевого продукта XVIII, что показано ниже на схеме; где Rпредставляет собой С-алкил, в частности, где Rпредставляет собой метил:4. Соль (1R,2R)-4-оксо-1,2-циклопентандикарбоновой кислоты с бруцином (1:2), имеющая структуру III.5. Соль (1R,2R)-4-оксо-1,2-циклопентандикарбоновой кислоты с (1R,2S)-(-)-эфедрином (1:2), имеющая структуру IV.6. Способ по п.
Claims (18)
1. Способ получения (1R,2R)-4-оксо-1,2-циклопентандикарбоновой кислоты II путем разрешения рацемической 4-оксо-1,2-циклопентандикарбоновой кислоты (V), причем указанный способ включает:
а) взаимодействие 4-оксо-1,2-циклопентандикарбновой кислоты (V) с бруцином или (1R,2S)-(-)-эфедрином с получением в результате бис-бруциновой или бис-(1R,2S)-(-)-эфедриновой соли соединения (V), и
b) селективное осаждение бис-бруциновой или бис-(1R,2S)-(-)-эфедриновой соли (1R,2R)-4-оксо-1,2-циклопентандикарбоновой кислоты II, при этом бис-бруциновая или бис-(1R,2S)-(-)-эфедриновая соль (1S,2S)-4-оксо-1,2-циклопентандикарбоновой кислоты остается в растворе;
с) высвобождение кислоты II путем удаления бруцина или (1R,2S)-(-)-эфедрина из осажденной соли, полученной на стадии (b);
что в общих чертах представлено на следующей реакционной схеме:
3. Способ получения циклопентанового производного XVIII, где бициклический лактон VII вводят в реакцию с N-метилгексенамином (NMHA) XVI в реакции амидообразования с получением амида бициклического лактона (XVII), в котором лактоновую группу раскрывают с получением целевого продукта XVIII, что показано ниже на схеме; где R1 представляет собой С1-4-алкил, в частности, где R1 представляет собой метил:
4. Соль (1R,2R)-4-оксо-1,2-циклопентандикарбоновой кислоты с бруцином (1:2), имеющая структуру III.
5. Соль (1R,2R)-4-оксо-1,2-циклопентандикарбоновой кислоты с (1R,2S)-(-)-эфедрином (1:2), имеющая структуру IV.
7. Способ по п.6, где органическим растворителем является ацетон, метилэтилкетон (МЕК), тетрагидрофуран (ТГФ), МеТГФ, СРМЕ (циклопентилметиловый эфир), С1-4-алкилацетат, С1-4-алкилпропионат, С1-4-алкилбутират или толуол, и триазин представляет собой 2,4,6-трихлор-1,3,5-триазин (ТСТ), хлордиметокситриазин (CDMT), дихлорметокситриазин (DCMT) или N-(3,5-диметокситриазинил)-N-метилморфолинийхлорид (DMTMM).
8. Способ получения промежуточного соединения формулы В, причем указанный способ включает: превращение промежуточного соединения II в сложный диметиловый эфир (1R,2R)-4-оксо-1,2-циклопентандикарбоновой кислоты VIII; восстановление кето-группы в соединении VIII с получением промежуточного соединения IX, которое превращают в соединение X путем реакции переэтерификации по гидрокси-группе; превращение гидрокси-группы в соединении Х в хинолинильную простую эфирную группу в соединении XI с помощью реакции Мицуноби, которая включает инверсию несущего гидрокси-группу атома углерода; снятие бензильной группы в соединении XI с получением промежуточного соединения XII; сочетание последнего со сложным эфиром циклопентиламинокислоты до соединения XIII, в котором метиловый эфир гидролизуют с получением соединения XIV; сочетание соединения XIV с N-метилгексенамином с получением в результате промежуточного соединения В, что представлено на следующей схеме, где Quin означает хинолиновую группу формулы:
что в общих чертах показано на следующей реакционной схеме:
9. Способ получения промежуточного соединения формулы D, причем указанный способ включает: взаимодействие соединения Х с ароматической кислотой, азодикарбоксилатом и фосфином в реакции Мицуноби с получением соединения XIX; взаимодействие соединения XIX с ацетатом палладия и формиатом натрия с получением соединения ХХ; сочетание соединения ХХ с N-метил-5-гексен-1-амином XVI с получением соединения XXI; обработку соединения XXI основанием в метаноле с получением соединения XVIII (R1 = Ме); обработку соединения XVIII соединением формулы Quin-ОН, где Quin имеет значение, определенное в п.8, в реакции Мицуноби с получением в результате промежуточного соединения D:
где R2 представляет собой атом водорода, С1-4-алкил, арил, атом галогена, -SO2-C1-4-алкил, CN или NO2.
18. Соединение по пп.15, 16 или 17, где в соединении формулы XIX, соответственно XX или XXI, R2 представляет собой 4-NO2.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10156681 | 2010-03-16 | ||
EP10156681.8 | 2010-03-16 | ||
PCT/EP2011/053957 WO2011113859A1 (en) | 2010-03-16 | 2011-03-16 | Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2012143977A true RU2012143977A (ru) | 2014-04-27 |
RU2628081C2 RU2628081C2 (ru) | 2017-08-14 |
Family
ID=42342793
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2012143977A RU2628081C2 (ru) | 2010-03-16 | 2011-03-16 | Способы и промежуточные соединения для получения макроциклических ингибиторов протеазы hcv |
Country Status (12)
Country | Link |
---|---|
US (2) | US9586893B2 (ru) |
EP (2) | EP3239129A1 (ru) |
JP (2) | JP2013522273A (ru) |
KR (1) | KR20130034012A (ru) |
CN (1) | CN103249708A (ru) |
AU (1) | AU2011229164B2 (ru) |
BR (1) | BR112012023296B1 (ru) |
CA (1) | CA2793129A1 (ru) |
IL (1) | IL221242A (ru) |
MX (1) | MX2012010678A (ru) |
RU (1) | RU2628081C2 (ru) |
WO (1) | WO2011113859A1 (ru) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3239129A1 (en) * | 2010-03-16 | 2017-11-01 | Janssen Pharmaceuticals, Inc. | Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv |
AU2012311461B2 (en) * | 2011-09-22 | 2017-07-06 | Janssen Pharmaceuticals, Inc. | Processes and intermediates for preparing a macrocyclic protease inhibitor of HCV |
EP3237590B1 (en) * | 2014-12-22 | 2019-06-12 | Colgate-Palmolive Company | Unit dose fabric softener |
MA41812A (fr) * | 2015-03-27 | 2018-01-30 | Janssen Pharmaceuticals Inc | Procédés et intermédiaires pour la préparation d'un inhibiteur de protéase macrocyclique du vhc |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL8300536A (nl) * | 1983-02-14 | 1984-09-03 | Oce Andeno Bv | Optisch actief alfa-azido-p-hydroxyfenylazijnzuur en zijn zouten alsmede de bereiding daarvan. |
JPS6124539A (ja) * | 1984-07-11 | 1986-02-03 | Sagami Chem Res Center | 光学活性(r)−2,5,12−トリヒドロキシ−1,2,3,4−テトラヒドロナフタセン−6,11−ジオン−2−カルボン酸の取得方法 |
JPH06124539A (ja) | 1992-10-08 | 1994-05-06 | Sony Corp | ディジタルvtr |
JPH08231469A (ja) * | 1995-02-23 | 1996-09-10 | Nippon Kayaku Co Ltd | シクロペンタンカルボン酸誘導体及びその製造法 |
JPH11180930A (ja) * | 1997-12-22 | 1999-07-06 | Sumitomo Chem Co Ltd | 光学活性trans−シクロブタンジカルボン酸類の製造方法 |
DE10029139A1 (de) * | 2000-06-14 | 2002-01-03 | Sueddeutsche Kalkstickstoff | Verfahren zur Herstellung von Amiden oder Estern |
US7671032B2 (en) * | 2004-01-30 | 2010-03-02 | Medivir Ab | HCV NS-3 serine protease inhibitors |
EP1919899B1 (en) * | 2005-07-29 | 2011-01-19 | Tibotec Pharmaceuticals | Macrocyclic inhibitors of hepatitis c virus |
PE20070211A1 (es) | 2005-07-29 | 2007-05-12 | Medivir Ab | Compuestos macrociclicos como inhibidores del virus de hepatitis c |
US20070185346A1 (en) * | 2006-02-03 | 2007-08-09 | Vaidya Niteen A | Kit for automated resolving agent selection and method thereof |
MX2009008271A (es) * | 2007-02-01 | 2009-08-12 | Tibotec Pharm Ltd | Procesos e intermediarios para la preparacion de un inhibidor de proteasa macrocilico del vhc. |
EP3239129A1 (en) * | 2010-03-16 | 2017-11-01 | Janssen Pharmaceuticals, Inc. | Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv |
-
2011
- 2011-03-16 EP EP17166514.4A patent/EP3239129A1/en not_active Withdrawn
- 2011-03-16 JP JP2012557537A patent/JP2013522273A/ja not_active Withdrawn
- 2011-03-16 EP EP11709692.5A patent/EP2547645B1/en active Active
- 2011-03-16 BR BR112012023296-7A patent/BR112012023296B1/pt not_active IP Right Cessation
- 2011-03-16 AU AU2011229164A patent/AU2011229164B2/en not_active Ceased
- 2011-03-16 KR KR1020127024789A patent/KR20130034012A/ko not_active Application Discontinuation
- 2011-03-16 MX MX2012010678A patent/MX2012010678A/es active IP Right Grant
- 2011-03-16 RU RU2012143977A patent/RU2628081C2/ru not_active IP Right Cessation
- 2011-03-16 US US13/634,996 patent/US9586893B2/en not_active Expired - Fee Related
- 2011-03-16 CA CA2793129A patent/CA2793129A1/en not_active Abandoned
- 2011-03-16 CN CN2011800140694A patent/CN103249708A/zh active Pending
- 2011-03-16 WO PCT/EP2011/053957 patent/WO2011113859A1/en active Application Filing
-
2012
- 2012-08-01 IL IL221242A patent/IL221242A/en not_active IP Right Cessation
-
2016
- 2016-02-08 JP JP2016021576A patent/JP2016164143A/ja active Pending
-
2017
- 2017-02-10 US US15/429,250 patent/US20170152253A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP3239129A1 (en) | 2017-11-01 |
JP2016164143A (ja) | 2016-09-08 |
JP2013522273A (ja) | 2013-06-13 |
EP2547645A1 (en) | 2013-01-23 |
MX2012010678A (es) | 2012-10-15 |
CA2793129A1 (en) | 2011-09-22 |
AU2011229164B2 (en) | 2015-11-26 |
WO2011113859A1 (en) | 2011-09-22 |
US9586893B2 (en) | 2017-03-07 |
IL221242A (en) | 2016-04-21 |
EP2547645B1 (en) | 2018-07-04 |
RU2628081C2 (ru) | 2017-08-14 |
IL221242A0 (en) | 2012-10-31 |
US20130005976A1 (en) | 2013-01-03 |
US20170152253A1 (en) | 2017-06-01 |
BR112012023296B1 (pt) | 2018-07-03 |
AU2011229164A1 (en) | 2012-08-30 |
KR20130034012A (ko) | 2013-04-04 |
CN103249708A (zh) | 2013-08-14 |
BR112012023296A2 (pt) | 2016-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Abele et al. | Preparation of achiral and of enantiopure geminally disubstituted β‐amino acids for β‐peptide synthesis | |
RU2011105244A (ru) | Термическое разложение карбоксилатов аммония | |
RU2012143977A (ru) | Способы и промежуточные соединения для получения макроциклических ингибиторов протеазы hcv | |
RU2011133749A (ru) | Способ получения и выделения 2-ациламино-3-дифенилпропионовой кислоты | |
JP2005529861A5 (ru) | ||
JP6487568B2 (ja) | ラセミ体δ−ヒドロキシエステルの触媒的不斉水素化反応による動力学的分割およびその応用 | |
RU2009121819A (ru) | Производные моноацетата циклопентендиола | |
SU837321A3 (ru) | Способ получени производныхпРОСТАглАНдиНА | |
JP2013522273A5 (ru) | ||
WO2008120475A1 (ja) | 液相でラクトンおよびカルボン酸エステルを水素化するアルコール類の製造方法 | |
KR20130089157A (ko) | 신규 방법 | |
CA2111607A1 (en) | Enzymatic process for the stereoselective preparation of a hetero-bicyclic alcohol enantiomer | |
CN110981720B (zh) | 一种二芳基乙酸酯类化合物及制备方法 | |
JP2016513091A (ja) | (+)−トリシクロヒドロキシラクトンの製造方法 | |
Shi et al. | Design, Synthesis and Biological Evaluation of 2‐(2‐Aryl‐morpholino‐4‐yl) ethyl Esters of Indomethacin as Potential Cyclooxygenase‐2 (COX‐2) Inhibitors | |
RU2470912C2 (ru) | Способ рацемизации оптически активных альфа-аминоацеталей | |
RU2013126497A (ru) | Упрощение способа получения соединения-предшественника | |
CN107879967B (zh) | 1-氮杂螺[4.4]壬烷-6-酮的制备方法 | |
JP2000026381A (ja) | アミノアルコールの単離方法 | |
JP5099932B2 (ja) | フルオレノンイミンを用いた炭素−炭素結合生成反応 | |
CN110862325B (zh) | 一种(1r,3s)-3-氨基-1-环戊醇及其盐的制备方法 | |
RU2372351C2 (ru) | Полусинтетический способ получения десерпидина | |
RU2387640C1 (ru) | Способ получения 1-(аминоалкил)индолинов | |
JP6235473B2 (ja) | 大環状hcvプロテアーゼ阻害剤を製造するための方法および中間体 | |
JP2007513186A (ja) | 置換アミノアルコールの調製のためのプロセス |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20190317 |